Expansion Opportunities Hospira's recent closure of manufacturing facilities in North Carolina indicates potential opportunities for sales of new manufacturing technologies, equipment, and quality assurance solutions for remaining or new production sites.

Regulatory Compliance The company's involvement in recent drug recalls highlights a need for advanced quality monitoring, traceability, and regulatory compliance systems to enhance safety and mitigate future risks.

Biosimilar Growth Hospira's successful launch of biosimilars like infliximab presents opportunities to supply supporting products such as bioprocessing equipment, biologics packaging, and specialty pharmaceuticals or related services.

Sustainable Packaging Innovative, environmentally friendly packaging solutions like PVC/DEHP-free IV bags are aligned with Hospira’s efforts to reduce plastic waste, creating avenues for sustainable materials and eco-friendly manufacturing solutions.

Technological Enhancements Hospira’s focus on infusion technology and safety devices suggests demand for advanced medical devices, IoT-enabled infusion pumps, and digital health solutions to improve patient safety and operational efficiency.